Host-dependent control of early regulatory and effector T-cell differentiation underlies the genetic susceptibility of RAG2-deficient mouse strains to transfer colitis

Mucosal Immunology

Volumn 6, Issue 3, 2013, Pages 601-611

  Valatas, V ^a   He, J ^b   Rivollier, A ^c   Kolios, G ^d   Kitamura, K ^e   Kelsall, B L ^b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c LUND UNIVERSITY   (Sweden)

^d DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^e KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD103 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 12; INTERLEUKIN 23; RAG2 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD45RBHIGH T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GENETIC SUSCEPTIBILITY; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE DIFFERENTIATION; MESENTERY LYMPH NODE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SALMONELLA ENTERITIDIS; STRAIN DIFFERENCE; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

EID: 84876346865     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.102     Document Type: Article

References (53)

1. Xavier, R.J. & Podolsky, D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007).
2. Bouma, G. & Strober, W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521-533 (2003).
3. Strober, W., Fuss, I.J. & Blumberg, R.S. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20, 495-549 (2002).
4. Elson, C.O. et al. Monoclonal anti-interleukin 23 reverses active colitis in a Tcell-mediated model in mice. Gastroenterology 132, 2359-2370 (2007).
5. Leppkes, M. et al. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136, 257-267 (2009).
6. Yen, D. et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest 116, 1310-1316 (2006).
7. O'Connor, W. Jr. et al. A protective function for interleukin 17A in T cellmediated intestinal inflammation. Nat. Immunol 10, 603-609 (2009).
8. Hue, S. et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med 203, 2473-2483 (2006).
9. Kullberg, M.C. et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med 203, 2485-2494 (2006).
10. Uhlig, H.H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309-318 (2006).
11. Izcue, A. et al. Interleukin-23 restrains regulatory Tcell activity to drive Tcell-dependent colitis. Immunity 28, 559-570 (2008).
12. Mottet, C., Uhlig, H.H. & Powrie, F. Cutting edge: cure of colitis by CD4 +CD25 + regulatory T cells. J. Immunol. 170, 3939-3943 (2003).
13. Powrie, F., Correa-Oliveira, R., Mauze, S. & Coffman, R.L. Regulatory interactions between CD45RBhigh and CD45RBlow CD4 + T cells are important for the balance between protective and pathogenic cellmediated immunity. J. Exp. Med 179, 589-600 (1994).
14. Bluestone, J.A. & Abbas, A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253-257 (2003).
15. Coombes, J.L. et al. A functionally specialized population of mucosal CD103 + DCs induces Foxp3 + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med 204, 1757-1764 (2007).
16. Sun, C.M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med 204, 1775-1785 (2007).
17. Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260 (2007).
18. Curotto de Lafaille, M.A., Lino, A.C., Kutchukhidze, N. & Lafaille, J.J. CD25-T cells generate CD25+Foxp3 + regulatory T cells by peripheral expansion. J. Immunol. 173, 7259-7268 (2004).
19. Liang, S., Alard, P., Zhao, Y., Parnell, S., Clark, S.L. & Kosiewicz, M.M. Conversion of CD4 + CD25-cells into CD4+ CD25 + regulatory Tcells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 201, 127-137 (2005).
20. Thornton, A.M. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3 + T regulatory cells. J. Immunol. 184, 3433-3441 (2010).
21. Haribhai, D. et al. A central role for induced regulatory T cells in tolerance induction in experimental colitis. J. Immunol. 182, 3461-3468 (2009).
22. Leon, F. et al. Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis. J. Immunol. 177, 6974-6982 (2006).
23. Asseman, C., Mauze, S., Leach, M.W., Coffman, R.L. & Powrie, F. An essential role for interleukin 10 in the function of regulatory Tcells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004 (1999).
24. Ahern, P.P. et al. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33, 279-288 (2010).
25. Lohr, J., Knoechel, B. & Abbas, A.K Regulatory T cells in the periphery. Immunol. Rev. 212, 149-162 (2006).
26. Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M.C. & von Boehmer, H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227 (2005).
27. Friswell, M.K. et al. Site and strain-specific variation in gut microbiota profiles and metabolism in experimental mice. PLoS One 5, e85842010).
28. Laffont, S., Siddiqui, K.R. & Powrie, F. Intestinal inflammation abrogates the tolerogenic properties of MLN CD103 + dendritic cells. Eur. J. Immunol. 40, 1877-1883 (2010).
29. Bouma, G., Kaushiva, A. & Strober, W. Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses. Gastroenterology 123, 554-565 (2002).
30. Zwiers, A. et al. A polymorphism in the coding region of Il12b promotes IL-12p70 and IL-23 heterodimer formation. J. Immunol. 186, 3572-3580 (2011).
31. Hovhannisyan, Z., Treatman, J., Littman, D.R. & Mayer, L. Characterization of interleukin-17-producing regulatory Tcells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 140, 957-965 (2011).
32. Sakuraba, A., Sato, T., Kamada, N., Kitazume, M., Sugita, A. & Hibi, T. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology 137, 1736-1745 (2009).
33. van Beelen, A.J. et al. Stimulation ofthe intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27, 660-669 (2007).
34. Liu, G., Yang, K., Burns, S., Shrestha, S. & Chi, H. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat. Immunol. 11, 1047-1056 (2010).
35. Neurath, M.F. et al. The transcription factor T-bet regulates mucosal Tcell activation in experimental colitis and Crohn's disease. J. Exp. Med 195, 1129-1143 (2002).
36. Zhou, L., Chong, M.M. & Littman, D.R. Plasticity of CD4+ T cell lineage differentiation. Immunity 30, 646-655 (2009).
37. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006).
38. Doganci, A. et al. The IL-6R alpha chain controls lung CD4+CD25 + Treg development and function during allergic airway inflammation in vivo. J. Clin. Invest. 115, 313-325 (2005).
39. Pasare, C. & Medzhitov, R. Toll pathway-dependent blockade of CD4 + CD25 + T cell-mediated suppression by dendritic cells. Science 299, 1033-1036 (2003).
40. Zhou, L. et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967-974 (2007).
41. Diehl, S. et al. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13, 805-815 (2000).
42. Serada, S. et al. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encepha-lomyelitis. Proc. Natl. Acad. Sci. USA 105, 9041-9046 (2008).
43. Thakker, P., Leach, M.W., Kuang, W., Benoit, S.E., Leonard, J.P. & Marusic, S. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 178, 2589-2598 (2007).
44. Kaiga, T., Sato, M., Kaneda, H., Iwakura, Y., Takayama, T. & Tahara, H. Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12. J. Immunol. 178, 7571-7580 (2007).
45. Prochazkova, J., Pokorna, K. & Holan, V. IL-12 inhibits the TGF-beta-dependent T cell developmental programs and skews the TGF-beta-induced differentiation into a Th1-like direction. Immunobiology 217, 74-82 (2012).
46. Heiseke, A. F. et al. CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis. Gastro-enterology 142, 335-345 (2012).
47. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
48. Round, J. L. & Mazmanian, S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 107, 122042010).
49. Meylan, F. et al. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol 4, 172-185 (2011).
50. Sun, B. et al. Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response. J. Immunol. 159, 1004-1011 (1997).
51. Slingsby, J.H., Hogarth, M.B., Simpson, E., Walport, M.J. & Morley, B.J. New microsatellite polymorphisms identified between C57BL/6, C57BL/10, and C57BL/KsJ inbred mouse strains. Immunogenetics 43, 72-75 (1996).
52. Rioux, J.D. et al. Genetic variationinthe 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29, 223-228 (2001).
53. Brescianini, S., Trinh, T., Stoll, M., Schreiber, S., Rioux, J.D. & Daly, M.J. IBD5 is associatedwith an extensive complicated Crohn's disease feature: implications from genotype-phenotype analysis. Gut 56, 149-150 (2007).